# Antiemetic Fosaprepitant To Remedy Nausea and Vomiting

> **NCT06382012** · PHASE2,PHASE3 · RECRUITING · sponsor: **Montefiore Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Nausea and Vomiting
- Nausea
- Vomiting

## Interventions

- **DRUG:** Fosaprepitant 150 mg
- **DRUG:** Ondansetron 4 mg

## Key facts

- **NCT ID:** NCT06382012
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-13
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06382012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06382012, "Antiemetic Fosaprepitant To Remedy Nausea and Vomiting". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06382012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*